GE HealthCare Technologies Inc. $GEHC Shares Acquired by Humankind Investments LLC

Humankind Investments LLC grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 70.8% in the second quarter, HoldingsChannel reports. The institutional investor owned 28,009 shares of the company’s stock after buying an additional 11,609 shares during the period. Humankind Investments LLC’s holdings in GE HealthCare Technologies were worth $2,075,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently made changes to their positions in GEHC. Glenview Trust co increased its position in shares of GE HealthCare Technologies by 4.4% in the 1st quarter. Glenview Trust co now owns 3,294 shares of the company’s stock valued at $266,000 after acquiring an additional 139 shares during the period. Silver Oak Securities Incorporated grew its stake in GE HealthCare Technologies by 4.6% during the 2nd quarter. Silver Oak Securities Incorporated now owns 3,183 shares of the company’s stock valued at $236,000 after purchasing an additional 140 shares during the last quarter. Chicago Capital LLC increased its holdings in shares of GE HealthCare Technologies by 2.2% in the second quarter. Chicago Capital LLC now owns 6,551 shares of the company’s stock valued at $485,000 after purchasing an additional 141 shares during the period. Fort Washington Investment Advisors Inc. OH raised its stake in shares of GE HealthCare Technologies by 4.2% in the second quarter. Fort Washington Investment Advisors Inc. OH now owns 3,557 shares of the company’s stock worth $263,000 after purchasing an additional 143 shares during the last quarter. Finally, Golden State Wealth Management LLC raised its stake in shares of GE HealthCare Technologies by 7.4% in the second quarter. Golden State Wealth Management LLC now owns 2,138 shares of the company’s stock worth $158,000 after purchasing an additional 148 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $83.96 on Friday. The stock has a market capitalization of $38.25 billion, a price-to-earnings ratio of 17.35, a PEG ratio of 3.60 and a beta of 1.10. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The firm’s 50 day simple moving average is $76.82 and its 200-day simple moving average is $74.97. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $5.07 billion. During the same period in the previous year, the business posted $1.14 EPS. The business’s revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is presently 2.89%.

Analyst Upgrades and Downgrades

GEHC has been the topic of a number of recent research reports. Zacks Research lowered GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Citigroup lifted their price objective on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research note on Thursday. Wells Fargo & Company dropped their price objective on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a report on Thursday, October 30th. Weiss Ratings reissued a “hold (c)” rating on shares of GE HealthCare Technologies in a report on Monday, December 1st. Finally, BTIG Research restated a “buy” rating and set a $87.00 target price on shares of GE HealthCare Technologies in a research report on Friday, November 21st. Six research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $87.09.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.